AI System for Detection and Characterization of Chronic Enteropathies
Key facts
- Who runs it
- Istituti Clinici Scientifici Maugeri SpA
- Where
- Pavia, ItalySee the site
- Trial code
- Status
- Recruiting
- People taking part
- 380 people, planned
- Started
- 20 Feb 2025
- Expected to end
- 1 Mar 2028
- Type of study
- Observational, 3 groups
- Record updated
- 4 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Adult patients (age ≥18 years)
- Patients undergoing endoscopic investigation of the small bowel (endoscopy or capsule endoscopy)
Who cannot take part
- Inability to provide informed consent
Where in Italy
- ICS Maugeri IRCCSPavia, ItalyContact: Federico Biagi, MDTaking people
About the trial
What the trial wants to find out
Coeliac disease (CD) is an immune-mediated enteropathy leading to small intestinal mucosal atrophy. Diagnosis relies on serology and duodenal biopsies, but it can be complicated by patchy lesions and differential diagnosis with Non-Celiac Enteropathies (NCEs). This multicenter observational study aims to develop and validate an Artificial Intelligence (AI) system to detect and characterize small bowel mucosal atrophy and other pathological findings using endoscopic imaging. The study involves a retrospective phase for training the AI model and a prospective phase to validate its diagnostic accuracy compared to standard human assessment.
The 3 groups in the trial
- Enteropathy Cohort (CD/NCE)
Adult patients (\>=18 years) with suspected or confirmed Celiac Disease or Non-Celiac Enteropathies undergoing small bowel endoscopy.
- Control Cohort
Adult patients (\>=18 years) undergoing small bowel endoscopy who do not have enteropathy or other small bowel pathological lesions (negative controls).
- Other Small Bowel Lesion Cohort
Adult patients (\>=18 years) undergoing small bowel endoscopy who who do not have Celiac Disease or Non-Celiac Enteropathies but have other small bowel pathological lesions.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Development and Validation of an Artificial Intelligence System for Detection and Characterization of Small Bowel Mucosal Atrophy in Celiac Disease and Non-Celiac Enteropathies: A Multicenter Observational Study
- Record updated
- 4 February 2026